SPINE Volume 35, Number 7, pp 740 –746
©2010, Lippincott Williams & Wilkins
Cages Augmented With Mineralized Collagen and
Platelet-Rich Plasma as an Osteoconductive/Inductive
Combination for Interbody Fusion
Matti Scholz, MD,* Philipp Schleicher, MD,* Tanja Eindorf, MD,† Frank Friedersdorff, MD,†
Michael Gelinsky, PhD,‡ Ulla Ko ¨nig, PhD,‡ Andreas Sewing, PhD,§ Norbert P. Haas, MD,†
and Frank Kandziora, MD*
Study Design. After anterior cervical discectomy, fu-
sion was radiologically, biomechanically, and histologi-
cally assessed in a sheep spine fusion model.
Objective. To evaluate the efficacy of a platelet-rich
plasma (PRP) application combined with a mineralized
collagen matrix (MCM) as an alternative to autologous
cancellous iliac crest bone grafts in a spine fusion model.
Summary of Background Data. PRP has the ability to
stimulate bone and tissue healing. MCM is a recently
developed osteoconductive material. Up to now, no com-
parative evaluation of PRP in combination with a MCM at
the cervical spine has been performed in vivo.
Methods. Twenty-four sheep (N = 8/group) underwent
C3/4 discectomy and fusion: group 1, titanium cage filled
with autologous cancellous iliac crest bone graft; group 2,
titanium cage filled with MCM; and group 3, titanium cage
filled with MCM and PRP. Radiographic evaluation was
performed before surgery and after 1, 2, 4, 8, and 12
weeks, respectively. After 12 weeks, fusion sites were
evaluated using functional radiographic views and quan-
titative computed tomographic scans to assess bone min-
eral density. Furthermore, histomorphologic and histo-
morphometrical analyses were performed to evaluate
fusion.
Results. In comparison with the titanium cage group
filled with autologous cancellous iliac crest bone grafts
representing the control group, MCM-alone group
showed a slightly lower fusion rate in the radiographic
and the histomorphometrical analysis. The addition of
PRP could not enhance this finding. There was no signif-
icant difference between MCM and MCM + PRP group in
radiologic and histologic findings.
Conclusion. The MCM alone is not able to replace
autologous bone grafts. Early activation of the platelets
by calcium, which is released from mineralized collagen,
could be the reason for the insufficient osteoinductive
effect of PRP. In consequence, the combined application
of mineralized collagen and PRP had no significant os-
teoinductive effect in this model.
Key words: cervical spine, sheep, animal model, inter-
body fusion, mineralized collagen matrix, PRP, autolo-
gous bone graft. Spine 2010;35:740 –746
Cages filled with autologous cancellous bone graft (BG)
are widely used in spinal fusion procedures.
1
However,
harvesting the autograft is time consuming and results in
significant donor side morbidity.
2–4
Many different ideas
have been evaluated to avoid the use of autograft in spi-
nal fusion. Until today, only a small number of options
have demonstrated valuable results.
One promising option is the combination of collagen
and calcium phosphate, which seems to imitate effec-
tively the osteoconductive characteristics of autologous
bone. The properties of such composite materials have
been assessed in several studies, however, with variable
success.
5–10
One problem so far was to achieve a suitable
ratio of both components and a uniform distribution of
the calcium phosphate phase in a collagen sponge.
11
All
currently available mineralized collagen scaffolds con-
tain bovine type I collagen. The 3-dimensional and
chemical structure tries to mimic the architecture and
chemical composition of the extracellular matrix of bone
including collagen fibrils and the nanocrystalline hy-
droxyapatite mineral phase, forming a highly organized
nanocomposite.
9,10,12
Some of these porous constructs
have already demonstrated the ability to enhance pene-
tration of osseous cells and blood capillaries into the
material, resulting in faster ingrowth of bone.
10,12
Cellular events that follow tissue damage are con-
trolled among others by platelets and the released
growth factors. Platelets release a large variety of growth
factors and cytokines after they adhere, aggregate, and
form a fibrin mesh. Growth factors such as platelet-
derived growth factor, platelet factor 4, transforming
growth factor-, insulin-like growth factor, and others,
as well as fibrinogen, fibronectin, osteocalcin, and others
were found in platelet-rich plasma (PRP).
13
Impacts of
most of these factors on bone and tissue regeneration
have already been shown by many investigations.
2,14,15
In 1982, Knighton et al
16
described the capacity of
platelets and fibrin to stimulate and accelerate the bone
From the *Center for Spinal Surgery and Neurotraumatology, Trau-
maclinic Frankfurt/Main, Germany; †Center for Musculosceletal Sur-
gery, Charite ´—Universita ¨ tsmedizin Berlin, Berlin, Germany; ‡Max
Bergmann Center of Biomaterials, Institute of Materials Science, Tech-
nische Universita ¨ t Dresden, Dresden, Germany; and §Biomet Deut-
schland GmbH, Berlin, Germany.
Acknowledgment date: February 26, 2009. First revision date: July 6,
2009. Acceptance date: July 13, 2009.
The device(s)/drug(s) that is/are the subject of this manuscript is/are not
FDA-approved for this indication and is/are commercially available in
the United States.
Corporate/industry funds were received in support of this work. Al-
though one or more of the author(s) has/have received or will receive
benefits for personal or professional use benefits will be directed solely
to a research fund, foundation, educational institution, or other non-
profit organization which the author(s) has/have been associated.
Address correspondence and reprint requests to Matti Scholz, MD,
Center for Spinal Surgery and Neurotraumatology, Traumaclinic
Frankfurt/Main, Friedberger Landstraße 430, 60389 Frankfurt/Main,
Germany; E-mail: matti.scholz@bgu_frankfurt.de
740